Bodycote (LON:BOY) Posts Earnings Results

Bodycote (LON:BOYGet Free Report) announced its quarterly earnings results on Wednesday. The company reported GBX 44.40 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Bodycote had a return on equity of 4.34% and a net margin of 3.91%.

Here are the key takeaways from Bodycote’s conference call:

  • Executives highlighted active portfolio reshaping under the Optimise programme — including the sale/closure of multiple sites — and target increasing Specialist Technologies to 35–40% of the portfolio by 2028 with a planned full run‑rate saving of at least £15m by mid‑2026.
  • FY25 delivered broadly stable core organic revenue (‑0.3%) with stronger H2 momentum, but core margin fell ~160bps to 16.8% and adjusted EPS declined to £0.444; cash conversion remained healthy at 78% and the full‑year dividend was held at £0.23.
  • Energy and oil & gas were material headwinds — group oil & gas/project activity in Specialist Technologies fell ~40% and energy‑related revenues were down around 25%, removing high‑margin work and pressuring divisional profitability.
  • Management reported strong end‑market momentum in Aerospace & Defense (significant H2 acceleration) and industrial gas turbines, which they expect to drive a return to core organic growth and margin expansion in 2026.
  • Capital allocation balances growth and returns — an additional £80m buyback announced (to complete by end‑2027), leverage at ~0.6x provides M&A firepower, and bolt‑on deals (e.g., Spectrum, Lake City) plus a >50‑target pipeline support targeted expansion.

Bodycote Stock Performance

BOY stock traded up GBX 23 during mid-day trading on Wednesday, reaching GBX 731. 149,105 shares of the stock traded hands, compared to its average volume of 697,526. The firm has a market capitalization of £1.26 billion, a PE ratio of 45.69, a P/E/G ratio of 1.44 and a beta of 1.22. The business has a 50-day moving average of GBX 751.85 and a two-hundred day moving average of GBX 684.87. Bodycote has a 52 week low of GBX 449.40 and a 52 week high of GBX 800. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 29.79.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on BOY shares. JPMorgan Chase & Co. restated a “neutral” rating on shares of Bodycote in a research note on Tuesday, January 6th. Jefferies Financial Group upped their price objective on shares of Bodycote from GBX 915 to GBX 925 and gave the stock a “buy” rating in a report on Monday, January 26th. Peel Hunt reissued a “buy” rating and set a GBX 845 target price on shares of Bodycote in a research report on Tuesday, November 18th. Deutsche Bank Aktiengesellschaft reduced their price target on Bodycote from GBX 860 to GBX 835 and set a “buy” rating for the company in a research report on Tuesday, November 18th. Finally, Berenberg Bank reiterated a “buy” rating and set a GBX 800 price target on shares of Bodycote in a research note on Friday, November 28th. Five analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 808.33.

Get Our Latest Report on Bodycote

About Bodycote

(Get Free Report)

The leading provider of heat treatment and specialist thermal processing services worldwide.

Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.

Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.

Recommended Stories

Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.